AYR.A.CN
Ayr Wellness Inc
Price:  
0.74 
CAD
Volume:  
63,310.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AYR.A.CN EV/EBITDA

401.9%
Upside

As of 2024-12-11, the EV/EBITDA ratio of Ayr Wellness Inc (AYR.A.CN) is 4.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AYR.A.CN's latest enterprise value is 678.46 mil CAD. AYR.A.CN's TTM EBITDA according to its financial statements is 149.16 mil CAD. Dividing these 2 quantities gives us the above AYR.A.CN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.7x - 7.9x 7.2x
Forward P/E multiples 8.3x - 10.8x 10.2x
Fair Price (0.68) - 8.38 3.71
Upside -192.4% - 1032.5% 401.9%
0.74 CAD
Stock Price
3.71 CAD
Fair Price

AYR.A.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-05 3.25
2024-12-04 3.19
2024-12-03 3.24
2024-12-02 3.27
2024-11-29 3.33
2024-11-28 3.34
2024-11-27 3.37
2024-11-26 3.36
2024-11-25 3.32
2024-11-22 3.34
2024-11-21 3.34
2024-11-20 3.40
2024-11-19 3.37
2024-11-18 3.41
2024-11-15 3.42
2024-11-14 3.43
2024-11-13 3.49
2024-11-12 3.52
2024-11-11 3.35
2024-11-08 3.54
2024-11-07 3.54
2024-11-06 3.61
2024-11-05 4.69
2024-11-04 4.84
2024-11-01 4.78
2024-10-31 4.58
2024-10-30 4.59
2024-10-29 4.65
2024-10-28 4.83
2024-10-25 4.83
2024-10-24 4.75
2024-10-23 4.75
2024-10-22 4.72
2024-10-21 4.41
2024-10-18 4.42
2024-10-17 4.41
2024-10-16 4.35
2024-10-15 4.31
2024-10-11 4.32
2024-10-10 4.29
2024-10-09 4.26
2024-10-08 4.29
2024-10-07 4.29
2024-10-04 4.33
2024-10-03 4.32
2024-10-02 4.26
2024-10-01 4.25
2024-09-30 4.27
2024-09-27 4.17
2024-09-26 4.13